De Giovanni Carla相关文献与解析，生知库

Early stability and late random tumor progression of a HER2-positive primary breast cancer patient-derived xenograft

HER2阳性原发性乳腺癌患者来源异种移植瘤的早期稳定性及晚期随机肿瘤进展

Landuzzi, Lorena; Palladini, Arianna; Ceccarelli, Claudio; Asioli, Sofia; Nicoletti, Giordano; Giusti, Veronica; Ruzzi, Francesca; Ianzano, Marianna L; Scalambra, Laura; Laranga, Roberta; Balboni, Tania; Arigoni, Maddalena; Olivero, Martina; Calogero, Raffaele A; De Giovanni, Carla; Dall'Ora, Massimiliano; Di Oto, Enrico; Santini, Donatella; Foschini, Maria Pia; Cucchi, Maria Cristina; Zanotti, Simone; Taffurelli, Mario; Nanni, Patrizia; Lollini, Pier-Luigi

HER2

Bioprofiling TS/A Murine Mammary Cancer for a Functional Precision Experimental Model

利用TS/A小鼠乳腺癌进行生物特征分析，构建功能精准的实验模型

期刊:Cancers

影响因子:4.4

doi:10.3390/cancers11121889

De Giovanni, Carla; Nicoletti, Giordano; Landuzzi, Lorena; Palladini, Arianna; Lollini, Pier-Luigi; Nanni, Patrizia

OX40 triggering concomitant to IL12-engineered cell vaccine hampers the immunoprevention of HER2/neu-driven mammary carcinogenesis

OX40 与 IL12 工程细胞疫苗同时激活会阻碍 HER2/neu 驱动的乳腺癌发生的免疫预防。

期刊:Oncoimmunology

影响因子:6.3

doi:10.1080/2162402X.2018.1465164

Nanni, Patrizia; De Giovanni, Carla; Burocchi, Alessia; Nicoletti, Giordano; Landuzzi, Lorena; Palladini, Arianna; Ianzano, Marianna Lucia; Arioli, Ivano; Colombo, Mario P; Lollini, Pier-Luigi

Genetic prevention of lymphoma in p53 knockout mice allows the early development of p53-related sarcomas

p53基因敲除小鼠淋巴瘤的基因预防作用可导致p53相关肉瘤的早期发展。

期刊:Oncotarget

影响因子:

doi:10.18632/oncotarget.2650

Landuzzi, Lorena; Ianzano, Marianna L; Nicoletti, Giordano; Palladini, Arianna; Grosso, Valentina; Ranieri, Dario; Dall'Ora, Massimiliano; Raschi, Elena; Laranga, Roberta; Gambarotti, Marco; Picci, Piero; De Giovanni, Carla; Nanni, Patrizia; Lollini, Pier-Luigi

淋巴瘤

发表日期：2014

文献求助收藏

Preclinical therapy of disseminated HER-2⁺ ovarian and breast carcinomas with a HER-2-retargeted oncolytic herpesvirus

利用靶向 HER-2 的溶瘤疱疹病毒对播散性 HER-2⁺ 卵巢癌和乳腺癌进行临床前治疗

期刊:PLoS Pathogens

影响因子:4.9

doi:10.1371/journal.ppat.1003155

Nanni, Patrizia; Gatta, Valentina; Menotti, Laura; De Giovanni, Carla; Ianzano, Marianna; Palladini, Arianna; Grosso, Valentina; Dall'ora, Massimiliano; Croci, Stefania; Nicoletti, Giordano; Landuzzi, Lorena; Iezzi, Manuela; Campadelli-Fiume, Gabriella; Lollini, Pier-Luigi

NEURO-ONCOLOGY IN DEVELOPING COUNTRIES

发展中国家的神经肿瘤学

期刊:Frontiers in Oncology

影响因子:3.3

doi:10.3389/fonc.2013.00151

Lollini, Pier-Luigi; De Giovanni, Carla; Nanni, Patrizia

Immune prevention of mammary carcinogenesis in HER-2/neu transgenic mice: a microarray scenario

HER-2/neu转基因小鼠乳腺癌发生的免疫预防：微阵列分析

期刊:Cancer Immunology Immunotherapy

影响因子:5.1

doi:10.1007/s00262-004-0635-4

Astolfi, Annalisa; Rolla, Simona; Nanni, Patrizia; Quaglino, Elena; De Giovanni, Carla; Iezzi, Manuela; Musiani, Piero; Forni, Guido; Lollini, Pier-Luigi; Cavallo, Federica; Calogero, Raffaele A

Gene expression analysis of immune-mediated arrest of tumorigenesis in a transgenic mouse model of HER-2/neu-positive basal-like mammary carcinoma.

在 HER-2/neu 阳性基底样乳腺癌转基因小鼠模型中，通过免疫介导的肿瘤发生阻滞进行基因表达分析

期刊:American Journal of Pathology

影响因子:3.6

doi:10.1016/S0002-9440(10)62339-5

Astolfi Annalisa, Landuzzi Lorena, Nicoletti Giordano, De Giovanni Carla, Croci Stefania, Palladini Arianna, Ferrini Silvano, Iezzi Manuela, Musiani Piero, Cavallo Federica, Forni Guido, Nanni Patrizia, Lollini Pier-Luigi

Concordant morphologic and gene expression data show that a vaccine halts HER-2/neu preneoplastic lesions

形态学和基因表达数据的一致性表明，疫苗可以阻止HER-2/neu癌前病变的发生。

期刊:Journal of Clinical Investigation

影响因子:13.6

doi:10.1172/JCI19850

Quaglino, Elena; Rolla, Simona; Iezzi, Manuela; Spadaro, Michela; Musiani, Piero; De Giovanni, Carla; Lollini, Pier Luigi; Lanzardo, Stefania; Forni, Guido; Sanges, Remo; Crispi, Stefania; De Luca, Pasquale; Calogero, Raffaele; Cavallo, Federica

HER Tyrosine Kinase Family and Rhabdomyosarcoma: Role in Onset and Targeted Therapy

HER酪氨酸激酶家族与横纹肌肉瘤：在发病和靶向治疗中的作用

Early stability and late random tumor progression of a HER2-positive primary breast cancer patient-derived xenograft

HER2阳性原发性乳腺癌患者来源异种移植瘤的早期稳定性及晚期随机肿瘤进展

Bioprofiling TS/A Murine Mammary Cancer for a Functional Precision Experimental Model

利用TS/A小鼠乳腺癌进行生物特征分析，构建功能精准的实验模型

OX40 triggering concomitant to IL12-engineered cell vaccine hampers the immunoprevention of HER2/neu-driven mammary carcinogenesis

OX40 与 IL12 工程细胞疫苗同时激活会阻碍 HER2/neu 驱动的乳腺癌发生的免疫预防。

Genetic prevention of lymphoma in p53 knockout mice allows the early development of p53-related sarcomas

p53基因敲除小鼠淋巴瘤的基因预防作用可导致p53相关肉瘤的早期发展。

Preclinical therapy of disseminated HER-2⁺ ovarian and breast carcinomas with a HER-2-retargeted oncolytic herpesvirus

利用靶向 HER-2 的溶瘤疱疹病毒对播散性 HER-2⁺ 卵巢癌和乳腺癌进行临床前治疗

NEURO-ONCOLOGY IN DEVELOPING COUNTRIES

发展中国家的神经肿瘤学

Immune prevention of mammary carcinogenesis in HER-2/neu transgenic mice: a microarray scenario

HER-2/neu转基因小鼠乳腺癌发生的免疫预防：微阵列分析

Gene expression analysis of immune-mediated arrest of tumorigenesis in a transgenic mouse model of HER-2/neu-positive basal-like mammary carcinoma.

在 HER-2/neu 阳性基底样乳腺癌转基因小鼠模型中，通过免疫介导的肿瘤发生阻滞进行基因表达分析

Concordant morphologic and gene expression data show that a vaccine halts HER-2/neu preneoplastic lesions

形态学和基因表达数据的一致性表明，疫苗可以阻止HER-2/neu癌前病变的发生。